Salvage therapy with pentostatin for steroid-refractory graft-versus-host disease

被引：0
|
作者：
Leopardi, G [1 ]
Visani, G [1 ]
Giardini, C [1 ]
Sparaventi, G [1 ]
d'Adamo, F [1 ]
Nicolini, G [1 ]
Guiducci, B [1 ]
Barulli, S [1 ]
Malerba, L [1 ]
Lucesole, M [1 ]
Isidori, A [1 ]
机构：
[1] San Salvatore Hosp, Pesaro, Italy
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [31] COMBINATION THERAPY WITH INOLIMOMAB AND ETANERCEPT FOR SEVERE STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    Van Groningen, L.
    Liefferink, A.
    de Haan, A.
    Schaap, N.
    Donnelly, P.
    Blijlevens, N.
    van der Velden, W.
    HAEMATOLOGICA, 2015, 100 : 279 - 279
  • [32] Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
    Nikiforow, Sarah
    Kim, Haesook T.
    Bindra, Bhavjot
    McDonough, Sean
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent T.
    Alyea, Edwin P., III
    Blazar, Bruce R.
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 804 - 811
  • [33] Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients
    Khandelwal, Pooja
    Teusink-Cross, Ashley
    Davies, Stella M.
    Nelson, Adam S.
    Dandoy, Christopher E.
    El-Bietar, Javier
    Marsh, Rebecca A.
    Kumar, Ashish R.
    Grimley, Michael S.
    Jodele, Sonata
    Myers, Kasiani C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1122 - 1127
  • [34] Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease
    Yalniz, Fevzi E.
    Hefazi, Mehrdad
    McCullough, Kristen
    Litzow, Mark R.
    Hogan, William J.
    Wolf, Robert
    Alkhateeb, Hassan
    Kansagra, Ankit
    Damlaj, Moussab
    Patnaik, Mrinal M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1478 - 1484
  • [35] Strategy on the Treatment of Steroid-Refractory Severe acute Graft-versus-Host Disease
    Yamin, T.
    Yi, L.
    Kaili, D.
    He, H.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S393 - S394
  • [36] Treatment of steroid-refractory acute graft-versus-host disease with ATG (Fresenius)
    Kamelander, J.
    Navratil, M.
    Koristek, Z.
    Doubek, M.
    Krejci, M.
    Brychtova, Y.
    Racil, Z.
    Mendelova, D.
    Weinreb, M.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S241 - S241
  • [37] Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease
    Benito, AI
    Furlong, T
    Martin, PJ
    Anasetti, C
    Appelbaum, FR
    Doney, K
    Nash, RA
    Papayannopoulou, T
    Storb, R
    Sullivan, KM
    Witherspoon, R
    Deeg, HJ
    TRANSPLANTATION, 2001, 72 (12) : 1924 - 1929
  • [38] Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
    Meunier, Mathieu
    Bulabois, Claude Eric
    Thiebaut-Bertrand, Anne
    Itzykson, Raphael
    Carre, Martin
    Carras, Sylvain
    Garban, Frederic
    Cahn, Jean Yves
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1451 - 1454
  • [39] Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease
    Radojcic, Vedran
    Pletneva, Maria
    Lee, Catherine J.
    Ivcevic, Sanja
    Sarantopoulos, Stefanie
    Couriel, Daniel
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (02) : E120 - E122
  • [40] How I treat steroid-refractory acute graft-versus-host disease
    Martin, Paul J.
    BLOOD, 2020, 135 (19) : 1630 - 1638
12345